Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Fulcrum Therapeutics Inc
Swot
Fulcrum Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Fulcrum Therapeutics Inc has 30 Strengths, 3 Weaknesses, 4 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(30)
Weakness
(3)
Opportunity
(4)
Threats
(1)
Others
(0)
Positive Breakout Second Resistance ( LTP > R2)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
High Normalized Momentum Score
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over the Quarter (3 Months)
Relative Outperformance versus Industry over 1 Year
Stocks whose current price is 20% higher than week low, and more than previous close
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
New 52 week high today
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Results Screener: Stocks with upcoming results which are seeing positive shifts in share price
Relative Outperformance versus Industry over 1 Month
Positive Breakout (LTP > R2)
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Stock gained more than 20% in one month
Annual Net Profits improving for last 2 years
Positive Breakout (LTP > R1)
Top Gainers
Stock with Low PE (PE < = 10)
RSI indicating price strength
Highest Recovery from 52 Week Low
Stocks Outperforming their Industry Price Change in the Quarter
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
Low Piotroski Score : Companies with weak financials
Companies with Upcoming Results
Mutual Funds Increased Shareholding in Past Month
Institutions increasing their shareholding
MFs increased their shareholding last quarter
Stocks rising sharply on very low month volumes
